All Hong Kong stocks quotes are at least 15 minutes delayed.
02888
STANCHART
HKD
191.300-2.100
(-1.09%)
1D
High
192.600
Open
192.600
VWAP
191.29
Vol
669.64K
Mkt Cap
--
Low
190.500
Amount
128.10M
EV/EBITDA(TTM)
-2.23
Total Shares
--
EV
-18.72B
EV/OCF(TTM)
-0.96
P/S(TTM)
3.03
Standard Chartered PLC is an international banking group. Its businesses include Corporate & Investment Banking (CIB), Wealth & Retail Banking (WRB), and Ventures. CIB supports large corporations, development organisations, governments, banks and investors in accessing cross-border trade and investment opportunities. CIB offers transaction banking, Islamic banking, insights, and others. WRB serves the local and international banking needs of clients across the wealth continuum from personal to priority and private banking, as well as small and medium enterprises. WRB offers international banking, global private banking, priority private, priority banking, SME banking, and wealth solutions. Ventures invests in disruptive financial technology and creates alternative financial service business models, as well as growing its digital banks, Mox and Trust. Mox is a digital bank that allows customers to spend, save, borrow, invest, and access lifestyle benefits in a single application.
Show More
News
1.0
09:30 AMaastocksChina and UK Aim to Restore 'Golden Era' Business Discussions During UK PM's Visit to China: Report
UK-China Business Dialogue: The UK and China are set to revive the "Golden Era" business dialogue during Prime Minister Keir Starmer's upcoming visit to China, with participation from major companies from both nations.
Participating Companies: Notable UK companies involved include AstraZeneca, BP, and HSBC, while Chinese firms include Bank of China and BYD Company.
Impact of US Politics: US President Donald Trump's comments regarding Greenland may influence Starmer's visit, highlighting the interconnectedness of international relations.
Visit Details: The UK is expected to announce specifics about Starmer's itinerary and visit arrangements soon, following the recent approval of a new site for the Chinese Embassy in the UK.
7.0
02:44 AMaastocksBarclays Favors HSBC Holdings, Anticipates Earnings to Surpass Expectations
HSBC Earnings Outlook: Barclays predicts HSBC will significantly exceed earnings guidance due to favorable conditions in Hong Kong and the integration of Hang Seng Bank, maintaining an Overweight rating and raising the target price from GBP12.3 to GBP14.
US Interest Rates Impact: The bank's net interest income (NII) is expected to remain 4-5% above market consensus even if US interest rates fall to 2%, indicating resilience in HSBC's performance.
Standard Chartered Performance: Barclays anticipates Standard Chartered will improve its return on tangible equity (RoTE) to 15% by 2028, although 2026 may present challenges with a potential drop to 13%.
Standard Chartered Rating Update: The broker reaffirmed an Equalweight rating for Standard Chartered, increasing the target price from GBP16 to GBP19, reflecting a cautious but optimistic outlook.
4.5
01-19aastocksCICC Identifies Possible 'Blue Chip' Stocks for HSI Semi-Annual Adjustment Predictions (Table)
CICC Report on HSI Adjustments: CICC predicts potential blue chip stocks for inclusion in the HSI based on semi-annual adjustments and quantitative criteria, highlighting companies like ZIJIN GOLD INTL and YUM CHINA.
Short Selling and Inflows: The report details short selling ratios and inflows for various stocks, indicating market activity and investor sentiment towards companies such as BEONE MEDICINES and XPENG-W.
Potential Replacements for HANG SENG BANK: Following the delisting of HANG SENG BANK, companies like STANCHART and SWIREPROPERTIES are identified as potential candidates to fill the vacancy.
Market Performance Overview: The report includes a snapshot of stock performance, with some companies experiencing gains while others face declines, reflecting the mixed market conditions.
6.5
01-19aastocksCICC Forecasts Inclusion of ZIJIN GOLD INTL, BEONE MEDICINES, PICC P&C, and AKESO in HSI; STANCHART Likely to Take HANG SENG BANK's Place
Annual Review Announcement: The Hang Seng Indexes Company will announce the results of its annual review of major Hong Kong stock indices on February 13, which will impact the eligible stocks for Southbound Stock Connect.
Potential New Additions: CICC forecasts that ZIJIN GOLD INTL, YUM CHINA, and BEONE MEDICINES are likely to meet the inclusion criteria for the Hang Seng Index, while several other companies may fill the gap left by HANG SENG BANK's removal.
Market Capitalization Considerations: Companies like STANCHART, SWIREPROPERTIES, and SINO LAND are also potential candidates for inclusion based on market capitalization and industry coverage, though their inclusion remains uncertain.
Southbound Stock Connect Adjustments: CICC anticipates that 44 stocks, including JD INDUSTRIALS and CHUANGXIN IND, will become eligible for inclusion in Southbound Stock Connect, while 25 stocks may be removed from the list.
6.5
01-15aastocks<Research>G Sachs: APAC Banks Demonstrate Consistent Growth This Year; Indonesian Banks Preferred
Banking Growth Outlook: Goldman Sachs predicts continued growth in the banking sector for ASEAN and Hong Kong banks from 2025 into 2026, driven by strong deposit inflows rather than traditional loan growth.
Profitability Expectations: Regional banks are expected to see improved profitability and potential upward revisions in earnings guidance, particularly for Indonesian banks due to easing funding cost pressures.
Valuation Insights: Compared to global peers, regional banks' valuations remain undemanding, suggesting room for growth and positive catalysts in the coming years.
Stock Ratings: Various banks across Thailand, Indonesia, Singapore, and the Philippines received updated ratings and target prices, with several banks in Indonesia and Singapore being rated as "Buy."
Money Flow
Over the past 66 trading days, overall net money flow is -57.06M, with retail investors contributing 1.39M and major investors adding -81.02M.
Net Buy $ Volume
Net Sell $ Volume
JPMorgan
JPMorgan
Overweight
maintain
$190
2025-12-09
Reason
The analyst rating for STANCHART (02888.HK) is maintained at "Overweight" by JPMorgan due to the belief that the recent litigation settlement will have a limited negative impact on the company's operational results or financial condition. Although the settlement may reduce the CET1 ratio and potentially limit share buyback upside in 2026, JPMorgan expects the impact on the CET1 ratio to be less than approximately 13 basis points. The firm does not see this event as altering its overall investment view on STANCHART, hence the positive rating and target price of $190.
JPMorgan
Overweight
Price Target
$190
2025-12-09
maintain
The analyst rating for STANCHART (02888.HK) is maintained at "Overweight" by JPMorgan due to the belief that the recent litigation settlement will have a limited negative impact on the company's operational results or financial condition. Although the settlement may reduce the CET1 ratio and potentially limit share buyback upside in 2026, JPMorgan expects the impact on the CET1 ratio to be less than approximately 13 basis points. The firm does not see this event as altering its overall investment view on STANCHART, hence the positive rating and target price of $190.
Morgan Stanley
Morgan Stanley
upgrade
2025-11-04
Reason
The analyst rating from Morgan Stanley for STANCHART (02888.HK) is based on several key factors:
1. Strong Quarterly Results: STANCHART has reported strong quarterly results, which positively influences the outlook for the company's performance.
2. Increased Earnings Forecasts: Morgan Stanley raised its earnings forecasts for STANCHART for the years 2025, 2026, and 2027 by 11%, 3.5%, and 2%, respectively, indicating confidence in the company's future profitability.
3. Improved Return on Tangible Equity (ROTE) Guidance: The management of STANCHART has increased its ROTE guidance from approaching 13% to approximately 13%, suggesting better efficiency and profitability.
4. High Probability of Outperformance: The report estimates a 70-80% probability that STANCHART's share price will outperform its peers in the next 30 days, which is categorized as 'very likely.'
5. Target Price: Morgan Stanley has set a target price of $176.7 for STANCHART, reflecting their positive outlook and rating it as Overweight.
These factors collectively contribute to the positive analyst rating and outlook for STANCHART.
Morgan Stanley
Price Target
2025-11-04
upgrade
The analyst rating from Morgan Stanley for STANCHART (02888.HK) is based on several key factors:
1. Strong Quarterly Results: STANCHART has reported strong quarterly results, which positively influences the outlook for the company's performance.
2. Increased Earnings Forecasts: Morgan Stanley raised its earnings forecasts for STANCHART for the years 2025, 2026, and 2027 by 11%, 3.5%, and 2%, respectively, indicating confidence in the company's future profitability.
3. Improved Return on Tangible Equity (ROTE) Guidance: The management of STANCHART has increased its ROTE guidance from approaching 13% to approximately 13%, suggesting better efficiency and profitability.
4. High Probability of Outperformance: The report estimates a 70-80% probability that STANCHART's share price will outperform its peers in the next 30 days, which is categorized as 'very likely.'
5. Target Price: Morgan Stanley has set a target price of $176.7 for STANCHART, reflecting their positive outlook and rating it as Overweight.
These factors collectively contribute to the positive analyst rating and outlook for STANCHART.
JP Morgan
JP Morgan
maintain
$168 -> $190
2025-11-04
Reason
The analyst rating for Standard Chartered (STANCHART) is based on several key factors highlighted in the JP Morgan report. The reasons for the positive rating include:
1. Strong 3Q Results: Standard Chartered reported robust financial performance in the third quarter, which positively influenced the analysts' outlook.
2. Investor Meeting Insights: Insights gained from a meeting with the bank's CFO, Diego De Giorgi, contributed to a more favorable assessment of the bank's prospects.
3. Increased EPS Forecast: JP Morgan raised its earnings per share (EPS) forecast for Standard Chartered for the years 2025-2027 by 3-6%, driven by expectations of stronger revenue and lower provisions.
4. Target Price Increase: The target price for Standard Chartered was raised from HKD 168 to HKD 190, reflecting a forecasted 13% growth in EPS and a 14% adjusted return on tangible equity (ROTE) by 2028.
5. Overweight Rating: JP Morgan maintained an Overweight rating on Standard Chartered, indicating a positive outlook compared to other stocks in the sector.
Overall, the combination of strong financial results, improved forecasts, and positive insights from management led to the favorable analyst rating.
JP Morgan
Price Target
$168 -> $190
2025-11-04
maintain
The analyst rating for Standard Chartered (STANCHART) is based on several key factors highlighted in the JP Morgan report. The reasons for the positive rating include:
1. Strong 3Q Results: Standard Chartered reported robust financial performance in the third quarter, which positively influenced the analysts' outlook.
2. Investor Meeting Insights: Insights gained from a meeting with the bank's CFO, Diego De Giorgi, contributed to a more favorable assessment of the bank's prospects.
3. Increased EPS Forecast: JP Morgan raised its earnings per share (EPS) forecast for Standard Chartered for the years 2025-2027 by 3-6%, driven by expectations of stronger revenue and lower provisions.
4. Target Price Increase: The target price for Standard Chartered was raised from HKD 168 to HKD 190, reflecting a forecasted 13% growth in EPS and a 14% adjusted return on tangible equity (ROTE) by 2028.
5. Overweight Rating: JP Morgan maintained an Overweight rating on Standard Chartered, indicating a positive outlook compared to other stocks in the sector.
Overall, the combination of strong financial results, improved forecasts, and positive insights from management led to the favorable analyst rating.
Morgan Stanley
Morgan Stanley
maintain
$173
2025-10-31
Reason
The analyst rating from Morgan Stanley for STANCHART (02888.HK) was raised to Overweight due to an increase in their earnings forecasts for 2025-2027 by 11%, 3.5%, and 2% respectively, following the company's announcement of its 3Q25 results. Additionally, the target price was lifted from $173 to $176.7, and the broker lowered its 2025 credit expenditure forecast while largely maintaining credit loss forecasts for 2026 and 2027.
Morgan Stanley
Price Target
$173
2025-10-31
maintain
The analyst rating from Morgan Stanley for STANCHART (02888.HK) was raised to Overweight due to an increase in their earnings forecasts for 2025-2027 by 11%, 3.5%, and 2% respectively, following the company's announcement of its 3Q25 results. Additionally, the target price was lifted from $173 to $176.7, and the broker lowered its 2025 credit expenditure forecast while largely maintaining credit loss forecasts for 2026 and 2027.
UBS
UBS
maintain
GBX1,537
2025-10-30
Reason
The analyst rating for STANCHART (02888.HK) was upgraded to "Buy" by UBS due to the company's 3Q25 adjusted profit before tax being 15% above market consensus. Key factors contributing to this positive assessment include net interest income being 2% better than expected, underlying non-interest income being 5% higher, and effective cost control that led to pre-provision profit exceeding forecasts by 10%. Overall revenue growth was driven by strong performance in transaction services, global banking, and wealth management, despite some offset from a slowdown in the global market business. The target price set by UBS is GBX1,537.
UBS
Price Target
GBX1,537
2025-10-30
maintain
The analyst rating for STANCHART (02888.HK) was upgraded to "Buy" by UBS due to the company's 3Q25 adjusted profit before tax being 15% above market consensus. Key factors contributing to this positive assessment include net interest income being 2% better than expected, underlying non-interest income being 5% higher, and effective cost control that led to pre-provision profit exceeding forecasts by 10%. Overall revenue growth was driven by strong performance in transaction services, global banking, and wealth management, despite some offset from a slowdown in the global market business. The target price set by UBS is GBX1,537.
BofA Securities
BofA Securities
Underperform
maintain
GBX1,330
2025-10-30
Reason
The analyst rating for Standard Chartered (STANCHART) is "Underperform" due to concerns about the bank's valuation. Despite delivering impressive 3Q25 results that exceeded consensus expectations, BofA Securities views the bank's valuation at approximately 1.1x P/TBV for a projected return on tangible equity (ROTE) of about 13% (which is lowered to 11-12% when accounting for restructuring) as not being attractive. This valuation perspective led to a target price of GBX1,330 for the bank.
BofA Securities
Underperform
Price Target
GBX1,330
2025-10-30
maintain
The analyst rating for Standard Chartered (STANCHART) is "Underperform" due to concerns about the bank's valuation. Despite delivering impressive 3Q25 results that exceeded consensus expectations, BofA Securities views the bank's valuation at approximately 1.1x P/TBV for a projected return on tangible equity (ROTE) of about 13% (which is lowered to 11-12% when accounting for restructuring) as not being attractive. This valuation perspective led to a target price of GBX1,330 for the bank.
Goldman Sachs
Goldman Sachs
Neutral
maintain
$135 -> $168
2025-10-30
Reason
The analyst rating for STANCHART (02888.HK) was maintained as Neutral by Goldman Sachs, despite raising the target price by 24% from HKD135 to HKD168. This decision is based on the company's 3Q25 underlying earnings before tax exceeding market forecasts by 14% and 23%, driven by better-than-expected performance in net interest income, non-net interest income, operating expenses, and credit costs. The tax rate was also lower than anticipated. The overall positive earnings performance contributed to the target price increase, but the Neutral rating suggests a cautious outlook despite the strong results.
Goldman Sachs
Neutral
Price Target
$135 -> $168
2025-10-30
maintain
The analyst rating for STANCHART (02888.HK) was maintained as Neutral by Goldman Sachs, despite raising the target price by 24% from HKD135 to HKD168. This decision is based on the company's 3Q25 underlying earnings before tax exceeding market forecasts by 14% and 23%, driven by better-than-expected performance in net interest income, non-net interest income, operating expenses, and credit costs. The tax rate was also lower than anticipated. The overall positive earnings performance contributed to the target price increase, but the Neutral rating suggests a cautious outlook despite the strong results.
Morgan Stanley
Morgan Stanley
Equal-weight
maintain
GBX1,654
2025-10-30
Reason
Morgan Stanley maintained an Equal-weight rating on Standard Chartered (STANCHART) due to the bank's 3Q25 revenue exceeding both street consensus and the broker's original projections by 3% and 6%, respectively. The strong performance across all business lines and the guidance uplift are seen as positive indicators that should support the stock price. Despite this, the rating remains Equal-weight, suggesting a neutral outlook rather than a strong buy or sell recommendation.
Morgan Stanley
Equal-weight
Price Target
GBX1,654
2025-10-30
maintain
Morgan Stanley maintained an Equal-weight rating on Standard Chartered (STANCHART) due to the bank's 3Q25 revenue exceeding both street consensus and the broker's original projections by 3% and 6%, respectively. The strong performance across all business lines and the guidance uplift are seen as positive indicators that should support the stock price. Despite this, the rating remains Equal-weight, suggesting a neutral outlook rather than a strong buy or sell recommendation.
Goldman Sachs
Goldman Sachs
maintain
$135
2025-10-06
Reason
The analyst rating for STANCHART (02888.HK) is maintained at "Neutral" by Goldman Sachs, primarily due to the following reasons:
1. Profit Forecast: Goldman Sachs predicts a 6% year-over-year increase in adjusted profit before tax for 3Q25, amounting to US$1.9 billion, which is 12% above market consensus. This positive outlook is driven by an increase in non-interest income and a decrease in costs.
2. Net Interest Income Guidance: Management has indicated a decline in net interest income for the year, and the recent rise in HIBOR suggests a lower likelihood of net interest income exceeding expectations in 3Q25.
3. Adjusted Income Growth: The broker forecasts a 3% growth in adjusted income to US$5.04 billion for 3Q25, which is a slowdown compared to the 7% growth seen in 1H25.
4. Earnings Per Share (EPS) Expectations: EPS is expected to remain flat or increase by only 1%, indicating limited growth potential.
5. Target Price Adjustment: Despite the positive profit forecast, the cautious outlook on net interest income and EPS growth led Goldman Sachs to raise the target price to $135 while keeping the rating at Neutral.
Overall, the combination of strong profit expectations but cautious guidance on net interest income and EPS growth contributes to the Neutral rating.
Goldman Sachs
Price Target
$135
2025-10-06
maintain
The analyst rating for STANCHART (02888.HK) is maintained at "Neutral" by Goldman Sachs, primarily due to the following reasons:
1. Profit Forecast: Goldman Sachs predicts a 6% year-over-year increase in adjusted profit before tax for 3Q25, amounting to US$1.9 billion, which is 12% above market consensus. This positive outlook is driven by an increase in non-interest income and a decrease in costs.
2. Net Interest Income Guidance: Management has indicated a decline in net interest income for the year, and the recent rise in HIBOR suggests a lower likelihood of net interest income exceeding expectations in 3Q25.
3. Adjusted Income Growth: The broker forecasts a 3% growth in adjusted income to US$5.04 billion for 3Q25, which is a slowdown compared to the 7% growth seen in 1H25.
4. Earnings Per Share (EPS) Expectations: EPS is expected to remain flat or increase by only 1%, indicating limited growth potential.
5. Target Price Adjustment: Despite the positive profit forecast, the cautious outlook on net interest income and EPS growth led Goldman Sachs to raise the target price to $135 while keeping the rating at Neutral.
Overall, the combination of strong profit expectations but cautious guidance on net interest income and EPS growth contributes to the Neutral rating.
Valuation Metrics
Forward PE
N/A
5Y Average PE
0.83
Current PE
12.12
Overvalued PE
3.59
Undervalued PE
-1.94
Forward EV/EBITDA
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00
Forward PS
5Y Average PS
1.45
Current PS
2.62
Overvalued PS
1.80
Undervalued PS
1.09
Financials
Al Analysis
Annual
Quarterly
Trading Trends
Daily
Monthly
Buyback
Short Selling
People Also Watch